Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC

Published Date: 13 Sep 2024

Two-trial analysis shows about a 40% decreased risk of disease recurrence or death

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pollution exposure may affect lung cancer in women who have never smoked

2.

younger kidney cancer survivors are more susceptible to heart problems.

3.

Q&A: Breast cancer facts that could save lives

4.

A prostate cancer risk prediction algorithm could help target men at highest risk

5.

New imaging guidelines for head and neck cancers, a step toward practice change


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot